Early Kidney Injury Biomarkers in Gynecologic Laparoscopic Surgery

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18+
SponsorMedipol University

About this trial

This prospective observational study aims to evaluate early subclinical acute kidney injury associated with pneumoperitoneum and Trendelenburg positioning during gynecological laparoscopic surgery. Urinary neutrophil gelatinase-associated lipocalin (NGAL) and kidney injury molecule-1 (KIM-1) levels will be measured and normalized to urinary creatinine. Biomarker changes will be compared between patients undergoing surgery in 30° and 45° Trendelenburg positions. The study seeks to determine whether these biomarkers can detect early renal injury before clinically significant changes in serum creatinine occur.

Eligibility criteria

Qualifiers

None

Disqualifiers

None

Trial design

Treatments tested in this trial

  • Pneumoperitoneum and Trendelenburg Positioning

Treatment groups

50 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Medipol University

Lead sponsor

Istanbul Medipol University Hospital

Sponsor institution